Melanoma
📧 Sign up to get email alerts when something new happens for Melanoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2026-01-07Clinical Trial Update: Measuring Real Time Decision-Making About Ultraviolet Radiation (UVR) Protection
The clinical trial evaluating real-time decision-making about ultraviolet radiation protection in melanoma has completed, with results poste…
-
CLINICAL_TRIALS trial_result · 2025-12-31Clinical Trial Update: Nivolumab in Treating Patients With Stage IIB-IIC Melanoma That Can Be Removed by Surgery [Phase 2]
A Phase 2 trial evaluating Nivolumab for patients with surgically resectable Stage IIB-IIC melanoma has completed.
-
CLINICAL_TRIALS trial_result · 2025-12-30Clinical Trial Update: Contrast-enhanced Ultrasound for Sentinel Node Detection [Phase 2, Phase 3]
A Phase 2/Phase 3 clinical trial sponsored by The Netherlands Cancer Institute is evaluating contrast-enhanced ultrasound for sentinel lymph…
-
CLINICAL_TRIALS trial_result · 2025-12-30Clinical Trial Update: Comparison of Two Strategies for Counseling Skin Examination and Sun Protection in First-degree Relatives of Patients With Melanoma [NA]
A completed clinical trial comparing two strategies for counseling skin examination and sun protection in first-degree relatives of patients…
-
CLINICAL_TRIALS trial_result · 2025-12-29Clinical Trial Update: A Phase I Study With a Personalized NeoAntigen Cancer Vaccine in Melanoma [Phase 1]
A Phase I study of a personalized neoantigen cancer vaccine in melanoma has completed with results posted.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2025-12-23Clinical Trial Update: SX-682 Treatment in Subjects With Metastatic Melanoma Concurrently Treated With Pembrolizumab [Phase 1]
Phase 1 update of SX-682 in metastatic melanoma patients treated with pembrolizumab (stages III/IV); the trial is active but not recruiting.
-
CLINICAL_TRIALS trial_result · 2025-12-23Clinical Trial Update: A Study of GC101 TIL in Advanced Melanoma (BZ) [Phase 1, Phase 2]
Phase 1/2 study of GC101 TIL in advanced melanoma has completed, evaluating tumor-infiltrating lymphocyte therapy.
-
CLINICAL_TRIALS trial_result · 2025-12-19Clinical Trial Update: Prospective Randomized Study of Cell Transfer Therapy for Metastatic Melanoma Using Tumor Infiltrating Lymphocytes Plus IL-2 Following Non-Myeloablative Lymphocyte Depleting Chemo Regimen Alone or in Conjunction With 12Gy Total Body Irradiation (TBI... [Phase 2]
Phase 2 randomized trial evaluating adoptive cell therapy with tumor-infiltrating lymphocytes plus interleukin-2 in metastatic melanoma, wit…
-
CLINICAL_TRIALS trial_result · 2025-12-17Clinical Trial Update: Duvelisib in Combination With Nivolumab in Patients With Advanced Unresectable Melanoma [Phase 1, Phase 2]
A Phase 1/2 study evaluating the combination of duvelisib with nivolumab in patients with advanced unresectable melanoma has been terminated…
-
CLINICAL_TRIALS trial_result · 2025-12-17Clinical Trial Update: Nivolumab With Trametinib and Dabrafenib, or Encorafenib and Binimetinib in Treating Patients With BRAF Mutated Metastatic or Unresectable Stage III-IV Melanoma [Phase 2]
A Phase 2 clinical trial update evaluating two combination regimens for BRAFV600-mutant metastatic or unresectable melanoma: nivolumab with …
-
CLINICAL_TRIALS trial_result · 2025-12-17Clinical Trial Update: Efficacy of Daromun Neoadjuvant Intratumoral Treatment in Clinical Stage IIIB/C/D Melanoma Patients [Phase 3]
A Phase 3 neoadjuvant intratumoral treatment with Daromun is being studied in patients with clinical stage IIIB/IIIC/IIID melanoma, with rec…
-
CLINICAL_TRIALS trial_result · 2025-12-15Clinical Trial Update: A Study to Investigate the Novel Agent BNT111 and Cemiplimab in Combination or as Single Agents in Patients With Advanced Melanoma That Has Not Responded to Other Forms of Treatment [Phase 2]
A Phase 2 study evaluating BNT111 in combination with cemiplimab, or as single agents, in patients with advanced or unresectable melanoma th…
-
CLINICAL_TRIALS trial_result · 2025-12-15Clinical Trial Update: Prognostic and Treatment-Response Factors in Metastatic Melanoma: Multi-Center Analysis
This completed, multi-center analysis examines prognostic factors and treatment-response indicators in metastatic melanoma.
-
CLINICAL_TRIALS trial_result · 2025-12-12Clinical Trial Update: Adjuvant Dabrafenib and Trametinib Treatment in Patients With Completely Resected High-risk Stage III Melanoma.
This document provides an update on a completed clinical trial evaluating adjuvant dabrafenib and trametinib in patients with completely res…
-
CLINICAL_TRIALS trial_result · 2025-12-11Clinical Trial Update: Evaluating Length of Treatment With PD-1/PD-L1 Inhibitor in Advanced Solid Tumors [Phase 3]
Phase 3 trial evaluating the duration of PD-1/PD-L1 inhibitor therapy in advanced solid tumors; the study has completed.
-
CLINICAL_TRIALS trial_result · 2025-12-09Clinical Trial Update: Study of Lifileucel (LN-144), Autologous Tumor Infiltrating Lymphocytes, in the Treatment of Patients With Metastatic Melanoma [Phase 2]
Phase 2 results update for lifileucel (LN-144), autologous tumor-infiltrating lymphocytes, in patients with metastatic melanoma; results fro…
-
CLINICAL_TRIALS trial_result · 2025-12-08Clinical Trial Update: Pembrolizumab and EDP1503 in Advanced Melanoma [Phase 2]
Phase 2 trial of pembrolizumab in combination with EDP1503 for advanced melanoma was terminated, with results posted.
-
CLINICAL_TRIALS trial_result · 2025-12-03Clinical Trial Update: VSV-02 Compassionate Use in Advanced Solid Tumors [Phase 1]
Phase 1 trial update indicates compassionate-use testing of VSV-02 for advanced solid tumors, including melanoma, with recruitment ongoing a…
-
CLINICAL_TRIALS trial_result · 2025-12-03Clinical Trial Update: Intra-Lymphatic STI-3031 Using the Sofusa DoseConnect Device for Treatment of In-Transit Melanoma, The Sofusa-2 Study [Phase 1]
A Phase 1 study evaluating intra-lymphatic STI-3031 delivered with the Sofusa DoseConnect device for in-transit melanoma (clinical stage III…
-
CLINICAL_TRIALS trial_result · 2025-12-03Clinical Trial Update: A Study of MQ710 With and Without Pembrolizumab in People With Solid Tumor Cancer [Phase 1]
Phase 1 clinical trial evaluating MQ710 with and without pembrolizumab in solid tumors; the study is currently recruiting.
-
CLINICAL_TRIALS trial_result · 2025-11-28Clinical Trial Update: A Study to Evaluate the Safety and Efficacy of CyPep-1 in Combination With Pembrolizumab for the Treatment of Advanced or Metastatic Cancers [Phase 1, Phase 2]
Phase 1/2 study evaluating the safety and preliminary efficacy of CyPep-1 in combination with pembrolizumab for advanced or metastatic cance…
-
CLINICAL_TRIALS trial_result · 2025-11-28Clinical Trial Update: Study of ACC-1898 in Adult Participants With Advanced Solid Tumors [Phase 1]
Phase 1 study update for ACC-1898 in adults with advanced solid tumors; the trial is not yet recruiting.
-
CLINICAL_TRIALS trial_result · 2025-11-26Clinical Trial Update: BO-112 With Pembrolizumab in Unresectable Malignant Melanoma [Phase 2]
Phase 2 trial of BO-112 in combination with pembrolizumab for unresectable malignant melanoma has completed, with results posted.
-
CLINICAL_TRIALS trial_result · 2025-11-25Clinical Trial Update: Trial Of Hypofractionated Radiotherapy In Combination With MEDI4736 And Tremelimumab For Patients With Metastatic Melanoma And Lung, Breast And Pancreatic Cancers [Phase 1]
Phase 1 clinical trial evaluating hypofractionated radiotherapy in combination with durvalumab (MEDI4736) and tremelimumab in patients with …
-
CLINICAL_TRIALS trial_result · 2025-11-24Clinical Trial Update: Pembrolizumab and Lenvatinib in Patients With Brain Metastases From Melanoma or Renal Cell Carcinoma [Phase 2]
Phase 2 trial of pembrolizumab plus lenvatinib for brain metastases from melanoma or renal cell carcinoma has been terminated; the update no…